Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Celcuity Inc. - Common Stock (NQ:CELC)

9.890 -0.350 (-3.42%)
Streaming Delayed Price Updated: 2:11 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Celcuity Inc. - Common Stock

< Previous 1 2 3 Next >
Earnings Scheduled For March 31, 2025
Via Benzinga
An Overview of Celcuity's Earnings
Via Benzinga
Insights into Celcuity's Upcoming Earnings
Via Benzinga
CELC Stock Earnings: Celcuity Beats EPS for Q2 2024
CELC stock results show that Celcuity beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
CELC Stock Earnings: Celcuity Beats EPS for Q1 2024
CELC stock results show that Celcuity beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
CELC Stock Earnings: Celcuity Beats EPS for Q4 2023
CELC stock results show that Celcuity beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why Mitek Systems Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Recap: Celcuity Q4 Earnings
Via Benzinga
Celcuity Earnings Preview
Via Benzinga
A Preview Of Celcuity's Earnings
Via Benzinga
Preview: Celcuity's Earnings
Via Benzinga
A Preview Of Celcuity's Earnings
Via Benzinga
Celcuity's Earnings: A Preview
Via Benzinga
Earnings Scheduled For November 14, 2024
Via Benzinga
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
The 7 Best Short-Squeeze Stocks to Buy Now: September 2023
Explore the potential of the best short-squeeze stocks to buy now as companies attempt to prove pessimistic traders wrong. 
Via InvestorPlace
Celcuity: Q2 Earnings Insights
  Celcuity (NASDAQ:CELC) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
7 Short-Squeeze Stocks That Actually Might Make Sense
Although the concept of short-squeeze stocks is one best left for speculators, these ideas have a touch of rationality behind them. 
Via InvestorPlace
10 Short Squeeze Stocks To Watch: Yellow Corporation, Getty Images, Tupperware And More
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Earnings Outlook For Celcuity
  Celcuity (NASDAQ:CELC) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement. Analysts estimate that Celcuity will... 
Via Benzinga
Earnings Scheduled For March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.